1,739
Views
45
CrossRef citations to date
0
Altmetric
Research Paper

Comprehensive methylome analysis of ovarian tumors reveals hedgehog signaling pathway regulators as prognostic DNA methylation biomarkers

, , , , , , , , , , , , , & show all
Pages 624-634 | Received 26 Mar 2013, Accepted 24 Apr 2013, Published online: 10 May 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Ashok Sharma, Mustafa Albahrani, Wa Zhang, Christina N. Kufel, Smitha R. James, Kunle Odunsi, David Klinkebiel & Adam R. Karpf. (2019) Epigenetic activation of POTE genes in ovarian cancer. Epigenetics 14:2, pages 185-197.
Read now
Sumei Wang, Wanyin Wu & Francois X. Claret. (2017) Mutual regulation of microRNAs and DNA methylation in human cancers. Epigenetics 12:3, pages 187-197.
Read now
Diego M Marzese & Dave SB Hoon. (2015) Emerging technologies for studying DNA methylation for the molecular diagnosis of cancer. Expert Review of Molecular Diagnostics 15:5, pages 647-664.
Read now

Articles from other publishers (42)

Amrutha Menon, Noraini Abd-Aziz, Kanwal Khalid, Chit Laa Poh & Rakesh Naidu. (2022) miRNA: A Promising Therapeutic Target in Cancer. International Journal of Molecular Sciences 23:19, pages 11502.
Crossref
Jürgen Serth, Inga Peters, Bastian Hill, Tatjana Hübscher, Jörg Hennenlotter, Michael Klintschar & Markus Antonius Kuczyk. (2022) Age-Related DNA Methylation in Normal Kidney Tissue Identifies Epigenetic Cancer Risk Susceptibility Loci in the ANKRD34B and ZIC1 Genes. International Journal of Molecular Sciences 23:10, pages 5327.
Crossref
Takahiro Ebata, Satoshi Yamashita, Hideyuki Takeshima, Hiroshi Yoshida, Yoshiko Kawata, Nao Kino, Toshiharu Yasugi, Yasuhisa Terao, Kan Yonemori, Tomoyasu Kato & Toshikazu Ushijima. (2022) DNA methylation marker to estimate ovarian cancer cell fraction. Medical Oncology 39:5.
Crossref
Liru Wang, Mu Su, Mengyan Zhang, Hongyan Zhao, Hongli Wang, Jie Xing, Chenyu Guo, Dianshuang Zhou, Wenhui Xue, Haibo Lu & Yan Zhang. (2021) Accurate Prediction of Prognosis by Integrating Clinical and Molecular Characteristics in Colon Cancer. Frontiers in Cell and Developmental Biology 9.
Crossref
Adriana Fodor, Adriana Rusu, Gabriela Roman, Ramona Suharoschi, Romana Vulturar, Adela Sitar-Tăut & Angela Cozma. 2021. Medical Epigenetics. Medical Epigenetics 143 168 .
Ivana Baranova, Helena Kovarikova, Jan Laco, Iva Sedlakova, Filip Vrbacky, Dalibor Kovarik, Petr Hejna, Vladimir Palicka & Marcela Chmelarova. (2020) Identification of a four-gene methylation biomarker panel in high-grade serous ovarian carcinoma. Clinical Chemistry and Laboratory Medicine (CCLM) 58:8, pages 1332-1340.
Crossref
Wangang Gong, Maowei Ni, Zhongbo Chen & Zhiguo Zheng. (2020) Expression and clinical significance of methyl‑CpG binding domain protein 2 in high‑grade serous ovarian cancer. Oncology Letters 20:3, pages 2749-2756.
Crossref
Tzu-I Wu, Rui-Lan Huang, Po-Hsuan Su, Shih-Peng Mao, Chen-Hsuan Wu & Hung-Cheng Lai. (2019) Ovarian cancer detection by DNA methylation in cervical scrapings. Clinical Epigenetics 11:1.
Crossref
Alka Singh, Sameer Gupta & Manisha Sachan. (2019) Epigenetic Biomarkers in the Management of Ovarian Cancer: Current Prospectives. Frontiers in Cell and Developmental Biology 7.
Crossref
Rui‐Lan Huang, Hsiang‐Ju Chen, Lin‐Yu Chen, Tai‐Kuang Chao, Wei‐Yu Lin, Phui‐Ly Liew, Po‐Hsuan Su, Yu‐Chun Weng, Yu‐Chi Wang, Chi‐Chun Liao, Yaw‐Wen Hsu, Hui‐Chen Wang & Hung‐Cheng Lai. (2018) Epigenetic loss of heparan sulfate 3‐ O ‐sulfation sensitizes ovarian carcinoma to oncogenic signals and predicts prognosis . International Journal of Cancer 143:8, pages 1943-1953.
Crossref
Leonel Maldonado, Mariana Brait, Evgeny Izumchenko, Shahnaz Begum, Aditi Chatterjee, Tanusree Sen, Myriam Loyo, Alvaro Barbosa, Maria Luana Poeta, Eugene Makarev, Alex Zhavoronkov, Vito M. Fazio, Roberto Angioli, Carla Rabitti, Mate Ongenaert, Wim Van Criekinge, Maartje G. Noordhuis, Pauline de Graeff, G. Bea A. Wisman, Ate G.J. van der Zee & Mohammad O. Hoque. (2018) Integrated transcriptomic and epigenomic analysis of ovarian cancer reveals epigenetically silenced GULP1. Cancer Letters 433, pages 242-251.
Crossref
Ivana Baranova, Helena Kovarikova, Jan Laco, Ondrej Dvorak, Iva Sedlakova, Vladimir Palicka & Marcela Chmelarova. (2018) Aberrant methylation of PCDH17 gene in high-grade serous ovarian carcinoma. Cancer Biomarkers 23:1, pages 125-133.
Crossref
Yanina Natanzon, Ellen L. Goode & Julie M. Cunningham. (2018) Epigenetics in ovarian cancer. Seminars in Cancer Biology 51, pages 160-169.
Crossref
Phui-Ly Liew, Rui-Lan Huang, Yu-Chun Weng, Chia-Lang Fang, Tim Hui-Ming Huang & Hung-Cheng Lai. (2018) Distinct methylation profile of mucinous ovarian carcinoma reveals susceptibility to proteasome inhibitors. International Journal of Cancer 143:2, pages 355-367.
Crossref
Wei HanCong ZhangXiao-jiao GaoHua-bing WangFang ChenFang CaoYong-wei HuJun MaXing GuHou-zhong Ding. (2018) Clinicopathologic and Prognostic Significance of the Zinc Finger of the Cerebellum Family in Invasive Breast Cancer. Journal of Breast Cancer 21:1, pages 51.
Crossref
Min Li, Ruiqing Zheng, Yaohang Li, Fang-Xiang Wu & Jianxin Wang. (2018) MGT-SM: A Method for Constructing Cellular Signal Transduction Networks. IEEE/ACM Transactions on Computational Biology and Bioinformatics, pages 1-1.
Crossref
Sumei Wang & Wanyin Wu. 2018. Epigenetics in Human Disease. Epigenetics in Human Disease 109 139 .
Angela Lopomo & Fabio Coppedè. 2018. Epigenetic Mechanisms in Cancer. Epigenetic Mechanisms in Cancer 313 343 .
Tushar Tomar, Nicolette G. Alkema, Leroy Schreuder, Gert Jan Meersma, Tim de Meyer, Wim van Criekinge, Harry G. Klip, Heidi Fiegl, Els van Nieuwenhuysen, Ignace Vergote, Martin Widschwendter, Ed Schuuring, Ate G. J. van der Zee, Steven de Jong & G. Bea A. Wisman. (2017) Methylome analysis of extreme chemoresponsive patients identifies novel markers of platinum sensitivity in high-grade serous ovarian cancer. BMC Medicine 15:1.
Crossref
Po-Hsuan Su, Yao-Wen Hsu, Rui-Lan Huang, Yu-Chun Weng, Hui-Chen Wang, Yu-Chih Chen, Yueh-Ju Tsai, Chiou-Chung Yuan & Hung-Cheng Lai. (2017) Methylomics of nitroxidative stress on precancerous cells reveals DNA methylation alteration at the transition from in situ to invasive cervical cancer . Oncotarget 8:39, pages 65281-65291.
Crossref
Ping-Ying Chang, Yu-Ping Liao, Hui-Chen Wang, Yu-Chih Chen, Rui-Lan Huang, Yu-Chi Wang, Chiou-Chung Yuan & Hung-Cheng Lai. (2017) An epigenetic signature of adhesion molecules predicts poor prognosis of ovarian cancer patients. Oncotarget 8:32, pages 53432-53449.
Crossref
Wina Verlaat, Peter J.F. Snijders, Putri W. Novianti, Saskia M. Wilting, Lise M.A. De Strooper, Geert Trooskens, Johan Vandersmissen, Wim Van Criekinge, G. Bea A. Wisman, Chris J.L.M. Meijer, Daniëlle A.M. Heideman & Renske D.M. Steenbergen. (2017) Genome-wide DNA Methylation Profiling Reveals Methylation Markers Associated with 3q Gain for Detection of Cervical Precancer and Cancer. Clinical Cancer Research 23:14, pages 3813-3822.
Crossref
Hongwei Tan, Jin Qi, Guanghua Chu & Zhaoyang Liu. (2017) Tripartite Motif 16 Inhibits the Migration and Invasion in Ovarian Cancer Cells. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 25:4, pages 551-558.
Crossref
Rong Wang, Robert W. van Leeuwen, Aniek Boers, Harry G. Klip, Tim de Meyer, Renske D. M. Steenbergen, Wim van Criekinge, Ate G. J. van der Zee, Ed Schuuring & G. Bea A. Wisman. (2016) Genome-wide methylome analysis using MethylCap-seq uncovers 4 hypermethylated markers with high sensitivity for both adeno- and squamous-cell cervical carcinoma. Oncotarget 7:49, pages 80735-80750.
Crossref
Tushar Tomar, Steven de Jong, Nicolette G. Alkema, Rieks L. Hoekman, Gert Jan Meersma, Harry G. Klip, Ate GJ van der Zee & G. Bea A. Wisman. (2016) Genome-wide methylation profiling of ovarian cancer patient-derived xenografts treated with the demethylating agent decitabine identifies novel epigenetically regulated genes and pathways. Genome Medicine 8:1.
Crossref
Deepak N. Ayyala, David E. Frankhouser, Javkhlan-Ochir Ganbat, Guido Marcucci, Ralf Bundschuh, Pearlly Yan & Shili Lin. (2016) Statistical methods for detecting differentially methylated regions based on MethylCap-seq data. Briefings in Bioinformatics 17:6, pages 926-937.
Crossref
Meenal Rastogi, Sameer Gupta & Manisha Sachan. (2016) Biomarkers towards Ovarian Cancer Diagnostics: Present and Future Prospects. Brazilian Archives of Biology and Technology 59:0.
Crossref
Ang Sun. 2016. Gynecological Cancers. Gynecological Cancers 23 47 .
Rohit R Jadhav, Zhenqing Ye, Rui-Lan Huang, Joseph Liu, Pei-Yin Hsu, Yi-Wen Huang, Leticia B Rangel, Hung-Cheng Lai, Juan Carlos Roa, Nameer B Kirma, Tim Hui-Ming Huang & Victor X Jin. (2015) Genome-wide DNA methylation analysis reveals estrogen-mediated epigenetic repression of metallothionein-1 gene cluster in breast cancer. Clinical Epigenetics 7:1.
Crossref
Vincenza Precone, Valentina Del Monaco, Maria Valeria Esposito, Fatima Domenica Elisa De Palma, Anna Ruocco, Francesco Salvatore & Valeria D’Argenio. (2015) Cracking the Code of Human Diseases Using Next-Generation Sequencing: Applications, Challenges, and Perspectives. BioMed Research International 2015, pages 1-15.
Crossref
Fabio Coppedè, Angela Lopomo & Lucia Migliore. 2015. Personalized Epigenetics. Personalized Epigenetics 183 220 .
Jessica Tang, Fang Fang, Dave F. Miller, Jay M. Pilrose, Daniela Matei, Tim Hui-Ming Huang & Kenneth P. Nephew. 2015. Cancer Epigenetics. Cancer Epigenetics 653 675 .
Fang Fang, Joanne Munck, Jessica Tang, Pietro Taverna, Yinu Wang, David F.B. Miller, Jay Pilrose, Gavin Choy, Mohammad Azab, Katherine S. Pawelczak, Pamela VanderVere-Carozza, Michael Wagner, John Lyons, Daniela Matei, John J. Turchi & Kenneth P. Nephew. (2014) The Novel, Small-Molecule DNA Methylation Inhibitor SGI-110 as an Ovarian Cancer Chemosensitizer. Clinical Cancer Research 20:24, pages 6504-6516.
Crossref
Brittany N Lasseigne, Todd C Burwell, Mohini A Patil, Devin M Absher, James D Brooks & Richard M Myers. (2014) DNA methylation profiling reveals novel diagnostic biomarkers in renal cell carcinoma. BMC Medicine 12:1.
Crossref
Fang Fang, Qingyao Zuo, Jay Pilrose, Yinu Wang, Changyu Shen, Meng Li, Phillip Wulfridge, Daniela Matei & Kenneth P. Nephew. (2014) Decitabine reactivated pathways in platinum resistant ovarian cancer. Oncotarget 5:11, pages 3579-3589.
Crossref
Yan Wang, Guiling Li, Fengbiao Mao, Xianfeng Li, Qi Liu, Lin Chen, Lu Lv, Xin Wang, Jinyu Wu, Wei Dai, Guan Wang, Enfeng Zhao, Kai-Fu Tang & Zhong Sheng Sun. (2014) Ras-induced Epigenetic Inactivation of the RRAD (Ras-related Associated with Diabetes) Gene Promotes Glucose Uptake in a Human Ovarian Cancer Model. Journal of Biological Chemistry 289:20, pages 14225-14238.
Crossref
Ha T. Nguyen, Geng Tian & Mandi M. Murph. (2014) Molecular Epigenetics in the Management of Ovarian Cancer: Are We Investigating a Rational Clinical Promise?. Frontiers in Oncology 4.
Crossref
Sabita N. Saldanha & Trygve O. Tollefsbol. (2014) Pathway Modulations and Epigenetic Alterations in Ovarian Tumorbiogenesis. Journal of Cellular Physiology 229:4, pages 393-406.
Crossref
Klaas Mensaert, Simon Denil, Geert Trooskens, Wim Van Criekinge, Olivier Thas & Tim De Meyer. (2014) Next-generation technologies and data analytical approaches for epigenomics. Environmental and Molecular Mutagenesis 55:3, pages 155-170.
Crossref
Akihiro Matsunaga, Tsunekazu Hishima, Noriko Tanaka, Maria Yamasaki, Lui Yoshida, Makoto Mochizuki, Junko Tanuma, Shinichi Oka, Yukihito Ishizaka, Mari Shimura & Shotaro Hagiwara. (2014) DNA methylation profiling can classify HIV-associated lymphomas. AIDS 28:4, pages 503-510.
Crossref
Monjri M. Shah & Charles N. Landen. (2014) Ovarian cancer stem cells: Are they real and why are they important?. Gynecologic Oncology 132:2, pages 483-489.
Crossref
Janos Minarovits & Hans Helmut Niller. (2013) Patho-Epigenetics. Medical Epigenetics 1:1, pages 37-45.
Crossref